• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙轮状病毒住院患者的临床特征、医疗资源利用情况和直接医疗费用(2013-2018 年)。

Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013-2018).

机构信息

Pediatrics, Hospital Universitario de Basurto, Bilbao, Spain.

Paediatrics, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.

出版信息

Hum Vaccin Immunother. 2022 Nov 30;18(5):2046961. doi: 10.1080/21645515.2022.2046961. Epub 2022 Apr 18.

DOI:10.1080/21645515.2022.2046961
PMID:35435807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9196715/
Abstract

Rotavirus (RV) is the most common cause of severe gastroenteritis (GE) in infants and young children worldwide and is associated with a significant clinical and economic burden. The objective of this study was to analyze the characteristics, healthcare resource utilization and the direct medical costs related to RVGE hospitalizations in Spain. An observational, multicenter, cross-sectional study was conducted from June 2013 to May 2018 at the pediatric departments of 12 hospitals from different Spanish regions. Children under 5 years of age admitted to the hospital with a confirmed diagnosis of RVGE were selected. Data on clinical characteristics, healthcare resource use and costs were collected from patient records and hospital databases. Most children hospitalized for RVGE did not have any previous medical condition or chronic disease. Forty-seven percent had previously visited the Emergency Room (ER), 27% had visited a primary care pediatrician, and 15% had received pharmacological treatment prior to hospital admission due to an RVGE episode. The average length of a hospital stay for RVGE was 5.6 days, and the mean medical costs of RVGE hospitalizations per episode ranged from 3,940€ to 4,100€. The highest direct medical cost was due to the hospital stay. This study showed a high burden of health resource utilization and costs related to the management of cases of RVGE requiring hospitalization. RV vaccination with high coverage rates should be considered to minimize the clinical and economic impacts of this disease on the health-care system.

摘要

轮状病毒(RV)是全球婴幼儿严重胃肠炎(GE)的最常见原因,与重大的临床和经济负担相关。本研究的目的是分析西班牙轮状病毒肠炎(RVGE)住院患者的特征、医疗资源利用情况和直接医疗费用。这是一项 2013 年 6 月至 2018 年 5 月在西班牙 12 家不同地区医院儿科开展的观察性、多中心、横断面研究。入选的患者为因 RVGE 住院且确诊的 5 岁以下儿童。从患者病历和医院数据库中收集了临床特征、医疗资源利用和费用数据。大多数因 RVGE 住院的患儿无任何既往病史或慢性病。47%的患儿曾因 RVGE 到过急诊,27%的患儿曾看过初级保健儿科医生,15%的患儿在 RVGE 发作时因住院前接受过药物治疗。RVGE 住院的平均住院时间为 5.6 天,每例 RVGE 住院的平均医疗费用为 3940 欧元至 4100 欧元。最高的直接医疗费用归因于住院费用。本研究显示,与需要住院治疗的 RVGE 病例管理相关的卫生资源利用和费用负担较高。应考虑高覆盖率的 RV 疫苗接种,以尽量减少该疾病对医疗保健系统的临床和经济影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5923/9196715/803ec4e624d3/KHVI_A_2046961_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5923/9196715/803ec4e624d3/KHVI_A_2046961_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5923/9196715/803ec4e624d3/KHVI_A_2046961_F0001_B.jpg

相似文献

1
Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013-2018).西班牙轮状病毒住院患者的临床特征、医疗资源利用情况和直接医疗费用(2013-2018 年)。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2046961. doi: 10.1080/21645515.2022.2046961. Epub 2022 Apr 18.
2
Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018.2013-2018 年西班牙不同疫苗接种覆盖率省份的轮状病毒胃肠炎住院情况。
BMC Infect Dis. 2021 Nov 6;21(1):1138. doi: 10.1186/s12879-021-06841-x.
3
Multicenter prospective study on the burden of rotavirus gastroenteritis in children less than 3 years of age in Spain.西班牙3岁以下儿童轮状病毒肠胃炎负担的多中心前瞻性研究。
BMC Infect Dis. 2016 Oct 10;16(1):549. doi: 10.1186/s12879-016-1890-7.
4
Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study.7个欧洲国家社区获得性小儿轮状病毒胃肠炎的成本:REVEAL研究
J Infect Dis. 2007 May 1;195 Suppl 1:S36-S44. doi: 10.1086/516716.
5
Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.西班牙儿科轮状病毒胃肠炎(RVGE)负担及使用五价轮状病毒疫苗实施普遍疫苗接种计划的潜在获益。
BMC Public Health. 2010 Aug 10;10:469. doi: 10.1186/1471-2458-10-469.
6
Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.自费轮状病毒疫苗对西班牙巴伦西亚地区轮状病毒相关住院率及费用的长期影响
BMC Infect Dis. 2017 Apr 11;17(1):267. doi: 10.1186/s12879-017-2380-2.
7
Impact on affected families and society of severe rotavirus infections in Swedish children assessed in a prospective cohort study.在一项前瞻性队列研究中评估瑞典儿童严重轮状病毒感染对受影响家庭和社会的影响。
Infect Dis (Lond). 2018 May;50(5):361-371. doi: 10.1080/23744235.2017.1416162. Epub 2017 Dec 20.
8
Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.基于初级保健的监测估计拉脱维亚 5 岁以下急性胃肠炎儿童中轮状病毒胃肠炎的比例。
Hum Vaccin Immunother. 2019;15(6):1272-1278. doi: 10.1080/21645515.2018.1534515. Epub 2018 Oct 31.
9
A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis.一项关于轮状病毒胃肠炎住院儿童临床特征的4年研究。
Eur J Pediatr. 2009 Nov;168(11):1343-8. doi: 10.1007/s00431-009-0934-z. Epub 2009 Feb 11.
10
Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.日本名古屋市轮状病毒疫苗接种对急性肠胃炎负担的影响。
Vaccine. 2018 Jan 25;36(4):527-534. doi: 10.1016/j.vaccine.2017.12.006. Epub 2017 Dec 13.

本文引用的文献

1
Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018.2013-2018 年西班牙不同疫苗接种覆盖率省份的轮状病毒胃肠炎住院情况。
BMC Infect Dis. 2021 Nov 6;21(1):1138. doi: 10.1186/s12879-021-06841-x.
2
Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis.高度发达国家 5 岁以下儿童轮状病毒疾病和医疗保健利用情况:系统评价和荟萃分析。
Vaccine. 2021 May 21;39(22):2917-2928. doi: 10.1016/j.vaccine.2021.04.039. Epub 2021 Apr 29.
3
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.
利用疫苗减少抗生素使用并预防抗生素耐药性:世界卫生组织行动框架。
Clin Infect Dis. 2021 Aug 16;73(4):e1011-e1017. doi: 10.1093/cid/ciab062.
4
Variation in antibiotic prescription rates in febrile children presenting to emergency departments across Europe (MOFICHE): A multicentre observational study.在欧洲各急诊科就诊的发热儿童中抗生素处方率的差异(MOFICHE):一项多中心观察性研究。
PLoS Med. 2020 Aug 19;17(8):e1003208. doi: 10.1371/journal.pmed.1003208. eCollection 2020 Aug.
5
Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned.口服减毒活人类轮状病毒疫苗十五年的经验:对所获经验教训的思考
Expert Rev Vaccines. 2020 Aug;19(8):755-769. doi: 10.1080/14760584.2020.1800459. Epub 2020 Sep 4.
6
Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance's 2018 Vaccine Investment Strategy: report from an expert survey.疫苗对抗菌素耐药性的影响,为全球疫苗免疫联盟2018年疫苗投资战略提供信息:专家调查结果报告
F1000Res. 2019 Sep 24;8:1685. doi: 10.12688/f1000research.20100.1. eCollection 2019.
7
[What have we learnt about rotavirus in Spain in the last 10 years?].在过去十年里,我们在西班牙对轮状病毒有了哪些了解?
An Pediatr (Engl Ed). 2019 Sep;91(3):166-179. doi: 10.1016/j.anpedi.2019.01.024. Epub 2019 Apr 7.
8
Impact on affected families and society of severe rotavirus infections in Swedish children assessed in a prospective cohort study.在一项前瞻性队列研究中评估瑞典儿童严重轮状病毒感染对受影响家庭和社会的影响。
Infect Dis (Lond). 2018 May;50(5):361-371. doi: 10.1080/23744235.2017.1416162. Epub 2017 Dec 20.
9
Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC).轮状病毒疫苗接种第 5 次欧洲专家会议报告(EEROVAC)。
Hum Vaccin Immunother. 2018 Apr 3;14(4):1027-1034. doi: 10.1080/21645515.2017.1412019. Epub 2018 Jan 18.
10
Rotavirus infection.轮状病毒感染。
Nat Rev Dis Primers. 2017 Nov 9;3:17083. doi: 10.1038/nrdp.2017.83.